PPARG and metabolic dysfunction-associated steatohepatitis: PPARγ is indeed markedly overexpressed in the liver of obese patients with NAFLD and NASH, and its expression positively correlates with plasma insulin, HOMA-IR, and SREBP1-c mRNA levels and inversely correlates with adiponectin [128].